UT Health San Antonio Cancer Center, founded in 1974, is an NCI-designated Cancer Center in San Antonio, Texas. It is a component of the University of Texas Health Science Center, San Antonio which is located adjacently.

During the past decade, Cancer Therapy and Research Center conducted 62 clinical trials. In the 10-year time frame, 62 clinical trials started and 50 clinical trials were completed, i.e. on average, 80.6% percent of trials that started reached the finish line to date. In the past 5 years, 20 clinical trials started and 21 clinical trials were completed. i.e. 105% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Cancer Therapy and Research Center" #1 sponsor was "The University of Texas Health Science Center at San Antonio" with 43 trials, followed by "National Cancer Institute (NCI)" with 31 trials sponsored, "SWOG Cancer Research Network" with 24 trials sponsored, "Novartis Pharmaceuticals" with 11 trials sponsored and "Oncolytics Biotech" with 11 trials sponsored. Other sponsors include 88 different institutions and companies that sponsored additional 71 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Cancer Therapy and Research Center" #1 collaborator was "National Cancer Institute (NCI)" with 52 trials as a collaborator, "Cancer and Leukemia Group B" with 8 trials as a collaborator, "SWOG Cancer Research Network" with 7 trials as a collaborator, "NCIC Clinical Trials Group" with 6 trials as a collaborator and "North Central Cancer Treatment Group" with 6 trials as a collaborator. Other collaborators include 47 different institutions and companies that were collaborators in the rest 46 trials.

According to Clinical.Site data, the most researched conditions in "Cancer Therapy and Research Center" are "Unspecified Adult Solid Tumor, Protocol Specific" (23 trials), "Breast Cancer" (17 trials), "Colorectal Cancer" (8 trials), "Lung Cancer" (7 trials) and "Lymphoma" (7 trials). Many other conditions were trialed in "Cancer Therapy and Research Center" in a lesser frequency.

Most popular intervention types in "Cancer Therapy and Research Center" are "Drug" (180 trials), "Other" (48 trials), "Biological" (37 trials), "Radiation" (14 trials) and "Procedure" (13 trials). Other intervention types were less common.

The name of intervention was led by "Laboratory Biomarker Analysis" (22 trials), "Bevacizumab" (11 trials), "Carboplatin" (9 trials), "Paclitaxel" (9 trials) and "Placebo" (9 trials). Other intervention names were less common.

The vast majority of trials in "Cancer Therapy and Research Center" are 181 trials for "All" genders, 19 trials for "Female" genders and 8 trials for "Male" genders.

Currently, there are NaN active trials in "Cancer Therapy and Research Center". 1 are not yet recruiting, 19 are recruiting, 30 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 124 completed trials in Cancer Therapy and Research Center, 1 suspended trials, and 25 terminated clinical trials to date.

Out of the total trials that were conducted in Cancer Therapy and Research Center, 78 "Phase 1" clinical trials were conducted, 69 "Phase 2" clinical trials and 48 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 12 trials that are defined as “Not Applicable".